Seeking Clues to Equifax (EFX) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics

16.04.25 15:15 Uhr

Werte in diesem Artikel
Aktien

194,00 EUR -2,00 EUR -1,02%

Indizes

5.282,7 PKT 7,0 PKT 0,13%

Wall Street analysts expect Equifax (EFX) to post quarterly earnings of $1.41 per share in its upcoming report, which indicates a year-over-year decline of 6%. Revenues are expected to be $1.41 billion, up 1.8% from the year-ago quarter.Over the last 30 days, there has been a downward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.In light of this perspective, let's dive into the average estimates of certain Equifax metrics that are commonly tracked and forecasted by Wall Street analysts.Based on the collective assessment of analysts, 'Operating revenue- U.S. Information Solutions' should arrive at $481.42 million. The estimate indicates a year-over-year change of +3.5%.The consensus among analysts is that 'Operating revenue- Workforce Solutions' will reach $610.79 million. The estimate points to a change of +1.3% from the year-ago quarter.The average prediction of analysts places 'Operating revenue- Total International' at $322.96 million. The estimate suggests a change of +0.5% year over year.Analysts forecast 'Operating revenue- U.S. Information Solutions- Mortgage Solutions' to reach $40.64 million. The estimate points to a change of +7% from the year-ago quarter.Analysts' assessment points toward 'Operating revenue- U.S. Information Solutions- Financial Marketing Services' reaching $48.47 million. The estimate points to a change of +2.9% from the year-ago quarter.The collective assessment of analysts points to an estimated 'Operating revenue- Workforce Solutions- Verification Services' of $491.83 million. The estimate points to a change of +3.2% from the year-ago quarter.Analysts expect 'Operating revenue- U.S. Information Solutions- Online Information Solutions' to come in at $392.49 million. The estimate suggests a change of +3.2% year over year.Analysts predict that the 'Operating revenue- Workforce Solutions- Employer Services' will reach $119.12 million. The estimate indicates a change of -5.7% from the prior-year quarter.According to the collective judgment of analysts, 'Operating revenue- Asia Pacific' should come in at $78.07 million. The estimate suggests a change of -0.2% year over year.The consensus estimate for 'Operating revenue- Latin America' stands at $92.23 million. The estimate indicates a year-over-year change of +1.2%.It is projected by analysts that the 'Operating revenue- Europe' will reach $87.72 million. The estimate points to a change of +1.8% from the year-ago quarter.The combined assessment of analysts suggests that 'Operating revenue- Canada' will likely reach $64.81 million. The estimate indicates a year-over-year change of -1.5%.View all Key Company Metrics for Equifax here>>>Over the past month, Equifax shares have recorded returns of -4.3% versus the Zacks S&P 500 composite's -4.2% change. Based on its Zacks Rank #4 (Sell), EFX will likely underperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Equifax, Inc. (EFX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Equifax und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Equifax

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Equifax

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Equifax Inc.

Wer­bung

Analysen zu Equifax Inc.

DatumRatingAnalyst
05.02.2019Equifax HoldDeutsche Bank AG
26.10.2018Equifax Equal WeightBarclays Capital
14.12.2017Equifax Equal WeightBarclays Capital
13.11.2017Equifax HoldStifel, Nicolaus & Co., Inc.
13.11.2017Equifax Sector PerformRBC Capital Markets
DatumRatingAnalyst
13.11.2017Equifax HoldStifel, Nicolaus & Co., Inc.
19.09.2017Equifax OutperformRBC Capital Markets
22.03.2017Equifax BuyStifel, Nicolaus & Co., Inc.
10.02.2017Equifax OverweightBarclays Capital
10.02.2017Equifax BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
05.02.2019Equifax HoldDeutsche Bank AG
26.10.2018Equifax Equal WeightBarclays Capital
14.12.2017Equifax Equal WeightBarclays Capital
13.11.2017Equifax Sector PerformRBC Capital Markets
23.10.2017Equifax Sector PerformRBC Capital Markets
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Equifax Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen